CLSD
Price:
$0.41
Market Cap:
$1.49M
Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to pioneering novel drug delivery methods to the posterior segment of the eye via the suprachoroidal space. Its commercial product, XIPERE, is a triamcinolone acetonide suprachoroidal injectable suspension designed for treating uveitis macular edema. The company's development pipeline also features CLS-AX, an axitinib injectable suspension administered into the suprachoroidal space, which is currently undergoing Phase 1/2a clinical trials. Additionally, they are advancing CLS-301, an integrin inhibitor suspension aimed at addressing diabetic macular edema and macular degeneration. Clearside maintains strategic partnerships w...[Read more]
Industry
Biotechnology
IPO Date
2016-06-02
Stock Exchange
NASDAQ
Ticker
CLSD
According to Clearside Biomedical, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.98. This represents a change of -17.63% compared to the average of 3.62 of the last 4 quarters.
The mean historical Current Ratio of Clearside Biomedical, Inc. over the last ten years is 5.71. The current 2.98 Current Ratio has changed 5.11% with respect to the historical average. Over the past ten years (40 quarters), CLSD's Current Ratio was at its highest in in the September 2016 quarter at 19.69. The Current Ratio was at its lowest in in the March 2020 quarter at 1.71.
Average
5.71
Median
4.26
Minimum
1.82
Maximum
15.59
Discovering the peaks and valleys of Clearside Biomedical, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 398.36%
Maximum Annual Current Ratio = 15.59
Minimum Annual Increase = -81.40%
Minimum Annual Current Ratio = 1.82
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 4.44 | 0.37% |
| 2023 | 4.42 | -48.24% |
| 2022 | 8.54 | -5.93% |
| 2021 | 9.08 | 398.36% |
| 2020 | 1.82 | -21.22% |
| 2019 | 2.31 | -43.57% |
| 2018 | 4.10 | 41.37% |
| 2017 | 2.90 | -81.40% |
| 2016 | 15.59 | 295.53% |
| 2015 | 3.94 | 14.80% |
The current Current Ratio of Clearside Biomedical, Inc. (CLSD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.80
5-year avg
5.66
10-year avg
5.71
Clearside Biomedical, Inc.’s Current Ratio is greater than CASI Pharmaceuticals, Inc. (0.30), greater than Cingulate Inc. (2.55), less than Lexaria Bioscience Corp. (26.88), less than Lisata Therapeutics, Inc. (4.23), greater than Allarity Therapeutics, Inc. (1.23), greater than Pelthos Therapeutics Inc. (2.76), greater than Entero Therapeutics, Inc. (0.16), less than Kairos Pharma, Ltd. (10.31), greater than MetaVia Inc. (2.73), less than Palisade Bio, Inc. (23.71),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.30 | $2.33M | |
| 2.55 | $27.36M | |
| 26.88 | $12.56M | |
| 4.23 | $32.42M | |
| 1.23 | $22.75M | |
| 2.76 | $17.83M | |
| 0.16 | $13.58M | |
| 10.31 | $9.42M | |
| 2.73 | $3.83M | |
| 23.71 | $296.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clearside Biomedical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Clearside Biomedical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Clearside Biomedical, Inc.'s Current Ratio?
How is the Current Ratio calculated for Clearside Biomedical, Inc. (CLSD)?
What is the highest Current Ratio for Clearside Biomedical, Inc. (CLSD)?
What is the 3-year average Current Ratio for Clearside Biomedical, Inc. (CLSD)?
What is the 5-year average Current Ratio for Clearside Biomedical, Inc. (CLSD)?
How does the current Current Ratio for Clearside Biomedical, Inc. (CLSD) compare to its historical average?